Subscribe
Home
Issues
Online First
Latest Issue
Issue Archive
Special Issues
Browse By Topic
Personalized Medicine
Economics & Value
FDA Approvals, News & Updates
COVID-19
Cholangiocarcinoma
View All Topics ›
Conference Correspondent
SABCS 2023 - HER2+ MBC
ASCO 2023 - Breast Cancer
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Prostate Cancer Diagnostics Monthly Minutes
Webinars
Quick Quizzes
Press Releases
AVBCC
Association for Value-Based Cancer Care
VBCM
Value-Based Care in Myeloma
AVBCC 2021 Summit
Exploring the Future of Genetic Therapies and Value-Based Care in Oncology
By
Wayne Kuznar
AVBCC 2021 Summit
April 2022, Vol 13, No 2
With better insights into the biology of cancer and other diseases, genetic medicine is entering “a whole new ballgame,” said Scott Gottlieb, MD, Former FDA Commissioner, during the keynote session at the 11th Annual Summit of the Association for Value-Based Cancer Care in 2021.
Read Article
Community-Based Providers Focus on Optimal Delivery of Care Despite Ongoing Challenges
By
Wayne Kuznar
AVBCC 2021 Summit
April 2022, Vol 13, No 2
Community-based providers remain at the core of the oncology care delivery system. A panel moderated by Barbara McAneny, MD, Chief Executive Officer, New Mexico Oncology Hematology Consultants, Albuquerque, at the 11th Annual Summit of the Association for Value-Based Cancer Care in 2021 explored the road ahead for community practices in terms of balancing value and delivering optimal access to care for patients.
Read Article
Oncology Pipeline Overview: Recent Approvals and Near-Term Drugs
By
Wayne Kuznar
AVBCC 2021 Summit
February 2022, Vol 13, No 1 Online Only
Many innovative therapies in oncology have made it to market recently, with a wealth of agents that are currently on the verge of FDA approval.
Read Article
Support Services for Patients with Cancer Must Go Beyond Simply Building a HUB
By
Wayne Kuznar
AVBCC 2021 Summit
February 2022, Vol 13, No 1 Online Only
The success of oncology support services developed by pharmaceutical manufacturers depends on tailoring programs that meet the needs of their specific patient populations, said panelists at a roundtable discussion on patient centricity and connectivity in oncology support and HUB services.
Read Article
AVBCC Panel Explores Value-Based Contracting in Oncology Care
AVBCC 2021 Summit
December 2021, Vol 12, No 6
At the 11th Annual Summit of the Association for Value-Based Cancer Care (AVBCC) in 2021, health plans and employers discussed the utility of value-based contracting for managing oncology care costs while maintaining focus on outcomes of value for patients.
Read Article
Future-Proofing Cancer Care Against Pandemics
By
William King
AVBCC 2021 Summit
December 2021, Vol 12, No 6
Enhanced flexibility in delivery, increased investment in digital capability, and quick adaptation to events were some of the positive impacts of the COVID-19 pandemic on cancer care.
Read Article
Drug Price Reform with Value in Mind: Is It Possible?
By
Wayne Kuznar
AVBCC 2021 Summit
December 2021, Vol 12, No 6
Oncologic drug pricing is being transformed with greater value in mind. At the 11th Annual Summit of the Association for Value-Based Cancer Care in 2021, a panel led by moderator William McGivney, PhD, Managing Principal, McGivney Global Advisors, Wayne, PA, discussed innovation in drug pricing, how the current rebate system supports higher drug costs, balancing new interventions with profits, and the implications of drug price negotiations being considered in Congress.
Read Article
The Impact of Telehealth on Quality, Access, and Cost in Cancer Care
By
Wayne Kuznar
AVBCC 2021 Summit
December 2021, Vol 12, No 6
The use of telehealth in the fee-for-service program surged by more than 4000% during the first 6 months of the COVID-19 pandemic.
Read Article
Reducing Racial Disparities in Cancer Care
By
William King
AVBCC 2021 Summit
December 2021, Vol 12, No 6
Reducing disparities in cancer care, including those affecting research and treatment, requires a better understanding of the history of racism, noted experts during a panel discussion at the 11th Annual Summit of the Association for Value-Based Cancer Care in 2021. The panel, which was moderated by Sybil Green, JD, RPh, MHA, Diversity and Inclusion Officer, American Society of Clinical Oncology, examined barriers to equitable care and potential solutions to remove these barriers.
Read Article
Biosimilars and the Road Ahead
By
Wayne Kuznar
AVBCC 2021 Summit
December 2021, Vol 12, No 6
Currently, 31 biosimilar products have been approved by the FDA, 20 of which have been launched in the United States.
Read Article
Page 1 of 2
1
2
View the Latest Issue of VBCC
Read Issue
Top Trending Articles
1.
Medication Assurance Programs, as Deceiving and Harmful as Alternate Funding Programs
Dawn Holcombe, MBA, FACMPE, ACHE
2.
Addressing Challenges to Adoption of Value-Based Agreements
Phoebe Starr
3.
Luspatercept Yields Improved Transfusion Independence Compared With Epoetin Alfa in Patients With Lower-Risk MDS
Phoebe Starr
Home
Issues
Online First
Latest Issue
Issue Archive
Special Issues
Browse By Topic
Personalized Medicine
Economics & Value
FDA Approvals, News & Updates
COVID-19
Cholangiocarcinoma
View All Topics ›
Conference Correspondent
SABCS 2023 - HER2+ MBC
ASCO 2023 - Breast Cancer
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Prostate Cancer Diagnostics Monthly Minutes
Webinars
Quick Quizzes
Press Releases
AVBCC
Association for Value-Based Cancer Care
VBCM
Value-Based Care in Myeloma